Dorzagliatin

From Wikipedia, the free encyclopedia

Dorzagliatin is a glucokinase activator that is being developed to treat diabetes.[1] Unlike other diabetes drugs, it is intended to increase insulin sensitivity.[2]

Related Articles

Wikiwand AI